Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short Period-Reference-Cited by-同舟云学术

Amphotericin B as Primary Therapy for Cryptococcosis in Patients with AIDS: Reliability of Relatively High Doses Administered over a Relatively Short Period

Published:1995-02-01 Issue:2 Volume:20 Page:263-266
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

de Lalla F.,Pellizzer G.,Vaglia A.,Manfrin V.,Franzetti M.,Fabris P.,Stecca C.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/20/2/263/1070880/20-2-263.pdf

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal Macrocycle Antibiotic Amphotericin B—Its Present and Future. Multidisciplinary Perspective for the Use in the Medical Practice;Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry;2022-02-14

2. Clinical characteristics, Cryptococcus neoformans genotypes, antifungal susceptibility, and outcomes in human immunodeficiency virus-positive patients in Beijing, China;Journal of International Medical Research;2021-05

3. Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections;Infectious Diseases and Therapy;2021-02-01

4. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen;Journal of Antimicrobial Chemotherapy;2017-02-13

5. Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis;Antimicrobial Agents and Chemotherapy;2015-09-08